Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Bioorganic & Medicinal Chemistry Letters|January 8, 2008
New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systemsFabrizio Micheli, Giorgio Bonanomi, Simone Braggio, et al.Journal of Medicinal Chemistry|September 16, 2010
Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonistsFabrizio Micheli, Luca Arista, Barbara Bertani, et al.Bioorganic & Medicinal Chemistry Letters|July 29, 2009
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studiesIdriss Bennacef, Cristian A Salinas, Thomas A Bonasera, et al.Bioorganic & Medicinal Chemistry Letters|February 6, 2008
New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systemsFabrizio Micheli, Giorgio Bonanomi, Simone Braggio, et al.Bioorganic & Medicinal Chemistry|March 9, 2016
1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonistsFabrizio Micheli, Andrea Bernardelli, Federica Bianchi, et al.Journal of Medicinal Chemistry|August 27, 2016
1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor AntagonistsFabrizio Micheli, Alessia Bacchi, Simone Braggio, et al.Psychopharmacology|June 19, 2004
Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in ratsJane Gartlon, Philip Szekeres, Mark Pullen, et al.Journal of Medicinal Chemistry|November 7, 2009
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Luca Arista, Giorgio Bonanomi, et al.Biological Psychiatry|April 26, 2011
The AVPR1A gene and substance use disorders: association, replication, and functional evidenceBrion S Maher, Vladimir I Vladimirov, Shawn J Latendresse, et al.Journal of Medicinal Chemistry|September 18, 2007
1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Giorgio Bonanomi, Frank E Blaney, et al.Pageof 7